Inquiry Basket
Loading ......
Filter By Product Search for
GRN
GRN Full Name
granulin
GRN Introduction
Granulin is a family of secreted, glycosylated peptides that play diverse and critical roles in numerous biological processes across eukaryotic organisms. Encoded by the GRN gene (Gene ID: 2896 in humans), these peptides are derived from a single precursor protein known as progranulin (PGRN), also referred to as proepithelin or PC cell-derived growth factor (PCDGF). The GRN gene is located on human chromosome 17q21.31 and is ubiquitously expressed in various tissues, with particularly high levels in the bone marrow, lung, and monocytes. Initially identified as minor side fractions during the purification of antimicrobial peptides, granulins have since emerged as key regulators of cell growth, development, and tissue homeostasis, with implications in both health and disease.
Figure 1.Cartoon representation of the molecular structure of protein registered with 1g26 code.
Role in Neurodegenerative Disease
Mutations in the GRN gene are a leading cause of frontotemporal lobar degeneration (FTLD), specifically the TDP-43 proteinopathy subtype (FTLD-TDP). These loss-of-function mutations result in haploinsufficiency, reducing PGRN levels by about 50-70%. This deficiency leads to lysosomal dysfunction, enhanced neuroinflammation, and the pathological accumulation of TDP-43 in neurons. The resulting clinical syndrome is frontotemporal dementia (FTD), characterized by profound changes in behavior, personality, and language. Reduced PGRN levels are also implicated in other neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease.
Therapeutic Implications and Research Directions
The PGRN/granulin system is a major therapeutic target, especially for FTD-GRN. Strategies aim to boost PGRN levels using small-molecule chaperones that enhance PGRN trafficking and secretion, or through gene therapy approaches. Alternatively, inhibiting the proteolytic conversion of PGRN into granulins is being explored to preserve its neurotrophic and anti-inflammatory functions. In oncology, blocking PGRN signaling with monoclonal antibodies is under investigation. Furthermore, plasma or CSF PGRN level is a robust biomarker for diagnosing and predicting the onset of FTD in GRN mutation carriers, facilitating clinical trial enrollment. Research continues to unravel the distinct functions of individual granulin peptides and their receptor systems.
Alternate Names for GRN
GRN; granulin; GEP; GP88; PEPI; PGRN; CLN11; PCDGF; granulins; acrogranin; progranulin; proepithelin; granulin-epithelin; PC cell-derived growth factor;
Loading ......
